Related Experiment Video
Updated: Jun 25, 2025

Studying the Coding Profiles of Somatic Stimulation on Cardiac-locked Neuronal Responses in the Rat Spinal Dorsal Horn
Published on: May 23, 2025
A Comprehensive Analysis of Conventional Acupuncture and Pharmacological Approaches for Cardiac Arrhythmias: An
Tamam Mohamad1, Mahima Khatri2, Satesh Kumar3
1Department of Cardiology, Wayne State University/Detroit Medical Center, Detroit, MI, USA.
Insights
Acupuncture shows promise for managing cardiac arrhythmias, significantly reducing ventricular premature beats and improving atrial fibrillation/flutter recurrence rates compared to standard treatments. Further research is needed to define its role in treating supraventricular tachycardia and heart rate.
Area of Science:
- Integrative and Complementary Medicine
- Cardiology
- Clinical Research
Background:
- Cardiac arrhythmias (CAs) pose a significant global health challenge, with increasing prevalence, particularly in older populations.
- Existing pharmacological treatments for CAs have limitations and potential side effects, necessitating exploration of alternative therapeutic strategies.
- Acupuncture, a traditional Chinese medicine technique, is increasingly being investigated for its potential role in managing cardiovascular conditions.
Purpose of the Study:
- To conduct an umbrella review comparing the safety and effectiveness of acupuncture versus pharmacological treatments for cardiac arrhythmias.
- To address critical gaps in understanding the optimal therapeutic approaches for managing various types of CAs.
- To evaluate the quality and certainty of evidence from existing systematic reviews and randomized controlled trials (RCTs).
Main Methods:
- Systematic literature search of PubMed, EMBASE, and Cochrane Database of Systematic Reviews for data up to September 2023.
- Inclusion of peer-reviewed systematic reviews and meta-analyses based on RCTs.
- Assessment of evidence certainty using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method and review quality using AMSTAR 2 and Cochrane Collaboration tools.
Main Results:
- Acupuncture demonstrated a statistically significant reduction in the recurrence of ventricular premature beats (VPBs) compared to pharmacological treatment.
- While acupuncture showed a trend towards reduced recurrence for paroxysmal atrial fibrillation (AF)/atrial flutter and paroxysmal supraventricular tachycardia (SVT), these differences were not statistically significant.
- Acupuncture exhibited a favorable safety profile with effectively managed adverse events; however, its effect on heart rate reduction was not statistically significant and showed high heterogeneity.
Conclusions:
- Acupuncture appears effective in reducing the recurrence of VPBs and shows potential benefits for AF/atrial flutter, though not statistically significant.
- The current evidence does not support a significant benefit of acupuncture over pharmacological treatments for paroxysmal SVT or post-treatment heart rate.
- While acupuncture presents a promising safety profile and potential efficacy for specific arrhythmias, further rigorous research is essential to establish its definitive role in CA management.
Abstract:
With a global incidence of approximately 3.4% and an annual mortality rate of 3.7 million, cardiac arrhythmias (CAs) are a pressing global health issue. Their increasing prevalence, especially among older people, is intensifying the challenge for health care systems worldwide. This study aims to compare the safety and effectiveness of acupuncture and pharmacological treatments for CAs, addressing critical gaps in understanding optimal therapeutic approaches. A search of PubMed, EMBASE, and the Cochrane database of systematic reviews was performed to identify data compiled through September 2023 for this umbrella review. Randomized controlled trials (RCTs) as the foundation for meta-analyses and peer-reviewed systematic reviews were the primary focus of the literature search. The Grading of Recommendations Assessment, Development, and Evaluation method was used to assess the overall certainty of the evidence, whereas AMSTAR 2 and the Cochrane Collaboration tool were used to evaluate the quality of the included reviews. Following a comprehensive review, three systematic analyses of 27 RCTs were integrated. Acupuncture led to a slightly greater reduction in the recurrence rate of paroxysmal supraventricular tachycardia (SVT) compared to standard pharmaceutical therapy (risk ratio [RR], 1.06; 95% confidence interval [CI], 0.88-1.27; I2 = 56%; P = .55), although the difference was not statistically significant. In contrast, acupuncture significantly outperformed pharmacological treatment in the context of ventricular premature beats (VPBs) (RR, 1.16; 95 CI, 1.08-1.25; I2 = 0%; P < .0001). The reduction in paroxysmal atrial fibrillation (AF)/atrial flutter was increased with acupuncture, albeit without statistical significance (RR, 1.12; 95% CI, 0.88-1.42; I2 = 0%; P = .36). Acupuncture also led to a greater reduction in heart rate (HR) compared to pharmaceutical treatment despite notable heterogeneity and a lack of statistical significance (mean difference, -1.55; 95% CI, -41.37 to 38.28; I2 = 99%; P = .94). Adverse events were effectively managed, affirming the favorable safety profile of acupuncture. Our study suggests that acupuncture leads to a greater reduction in the recurrence rates of VPBs, AF, and atrial flutter but not significantly so in paroxysmal SVT or post-treatment HR. While promising for specific arrhythmias, the varying effectiveness of acupuncture underscores the need for further research and clinical assessment to determine its precise role and suitability in managing particular cardiac conditions.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

